Skip to main content
Clinical Trials/CTRI/2023/09/057743
CTRI/2023/09/057743
Not yet recruiting
Phase 2

Pharmaceutico Analytical and Clinical evaluation of Navayas Churna along with dhanya panchak kwatha in the management of subclinical Hypothyrodism

ATIONAL INSTITUTE OF AYURVEDA0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism
Sponsor
ATIONAL INSTITUTE OF AYURVEDA
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with subclinical hypothyroidism with TSH levels ranging from 5\.5µIU/ml
  • \- 15µIU/ml.
  • k/c/o subclinical hypothyroidism but still not taking Levothyroxine therapy.
  • Common symptoms subclinical hypothyroidism like fatigue, weight gain, dry skin, decreased appetite, oedema.

Exclusion Criteria

  • Patients suffering from congenital hypothyroidism, overt hypothyroidism, and secondary hypothyroidism.
  • Patients of hyperthyroidism, neoplasia, toxic goitre are excluded.
  • Patients who have undergone any type of thyroid surgery.
  • Patients suffering from systemic diseases like cardiac problems, diabetes, carcinomas etc.
  • Patients taking drugs known to alter thyroid hormone level (e.g., Amiodarone)
  • Recent hospitalization for major illness, to exclude with ESS (Euthyroid Sick Syndrome).
  • Patient having thyroxine.

Outcomes

Primary Outcomes

Not specified

Similar Trials